Sign Out
Clomifene Citrate (Ova-Mit) is indicated for the treatment of ovulatory failure in women desiring pregnancy. Therapy with Clomifene Citrate (Ova-Mit) will not be successful unless the woman though anovulatory is capable of ovulation and her partner is fertile.
Clomifene Citrate (Ova-Mit) is ineffective in patients with primary pituitary or primary ovarian failure and is indicated only for patients in whom ovulatory dysfunction has been demonstrated. Clomifene Citrate (Ova-Mit) is not a substitute for appropriate therapy of other conditions which may cause ovulatory dysfunctions (e.g. thyroid or adrenal disease).
Continue with Google